Frequently Asked Question:
The Europe insulin patch pumps market was valued at USD 394.8 Billion in 2022.
The Europe insulin patch pumps market is expected to grow at a CAGR of 10.50% between 2023 and 2030, reaching USD 794.1692918 Billion in 2030.
Pumps is the leading segment by type, holding around three-fifth of the share in value in 2022.
Hospital pharmacies are the leading segment and are expected to exhibit a share of more than three-fifth share in terms of value in 2022.
Tethered segment is expected to post the highest CAGR during the forecast period.
Diabetes 1 is expected to post the highest CAGR during the forecast period & leading the market share with more than 30% share in 2022.
The top players include Medtronic, Tandem Diabetes Care, Inc., Insulet Corporation, ViCentra B.V., F. Hoffmann-La Roche Ltd, Terumo Corporation, and others
The rising incidence of diabetes in Europe with Continuous advancements in technology & growing demand for non-invasive insulin delivery. are the major market drivers.
Insulin patch pumps can be relatively expensive compared to traditional insulin delivery methods like injections & insulin patch pumps have certain technical limitations compared to traditional insulin pumps restraint of the Europe insulin patch pumps industry.
Europe has an aging population, and age is a significant risk factor for developing diabetes & insulin patch pumps industry can leverage the concept of personalized medicine to offer tailored insulin delivery solutions are opportunities for the Europe insulin patch pumps industry.